RE: Pharmaceutical Tariffs and Avacta9 Apr 2025 07:23
I have the view that efficacious and less expensive solutions will always pull through. Avacta’s manufacturing a lot less expensive than ADCs so I’m not sure it would be detrimental to Avacta. A pure guess.
What is amusing, much like other moronic leaders their vision isn’t always shared by those that matter. The markets, financial being key. US 10 year bongs going crazy, were up 0.245% and for every 0.1% it costs around $36bn in more interest.
Anyway, the BoD here know a lot of disquiet at share price and with CLN conversion period next week it should be an interesting lead up to AACR. They know AGM not far off and if this continues they’ll feel the pressure. I’m expecting a solid few weeks and beyond but I’ve said that for a while!